NFYB and hepatocellular carcinoma: Next, we tested if combined NFYB gene KO and menin inhibition increases HCC cell death by generating polyclonal CRISPR-Cas9 lines targeting the NFYB gene with gRNAs (NFYBKO; Figure 5E).